If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

Share Price is delayed by 15 minutes
Get Live Data
8.25    0.00 (0.00%)
Bid:
6.00
Ask:
10.50
Spread: 4.50 (75.00%)
Market Cap: £2.73m
HYG Live PriceLast checked at - London Stock Exchange

Intraday Seneca Growth Share Chart

Interim Management Statement

24 Oct 2013 15:53

RNS Number : 3543R
Hygea VCT plc
24 October 2013
 



24 October 2013

 

 

HYGEA VCT PLC

 

INTERIM MANAGEMENT STATEMENT

 

 

Hygea vct plc ('the Company') presents its interim management statement for the period from 1 July 2013 to 24 October 2013. This constitutes the Company's second interim management statement for the financial year ending 31 December 2013, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3. This statement has been prepared solely to provide additional information in order to meet the requirements of the Disclosure and Transparency Rules and should not be relied on by shareholders, or any other party, for any other purpose.

 

The unaudited net asset value per ordinary share and the number of shares in issue at 30 September 2013 were 102.0p and 8,115,376 respectively (30 June 2013: 112.8p and 8,115,376 respectively). The net asset value at 30 September 2013 is stated after accruing for the interim dividend of 3p per share payable on 25 October 2013. There were no shares held in Treasury at either date.

 

No shares have been issued or repurchased during the period.

 

At 30 September 2013, the Company's assets included its portfolio of unlisted assets along with £382,785 in cash and £6,179,935 in AIM traded shares valued at bid price. The Scancell plc ('Scancell') share price declined from 44.1p at 30 June 2013 to 39.0p at 30 September 2013. This has further fallen to 31.25p at 23 October 2013. As previously reported, 500,000 Scancell shares have been sold during the period realising net proceeds of £246,300 leaving the Company owning 13,349,730 shares. In view of the significance of the Scancell holding within the portfolio, readers' attention is drawn to the recording dated 4 October 2013 of Scancell's investor day accessible on www.scancell.co.uk.

 

During the three months ended 30 September 2013, the Company made a further investment of £100,008 into Eykona Technologies Limited and £200,000 into OR Productivity Limited.

 

The Directors are not aware of any other events which have taken place between 30 September 2013 and the date of publication of this statement, which have had a material effect on the financial position of the Company.

 

 

Enquiries:

James Otter, Hygea vct plc on 01730 829877 or james.otter@ellipson.co.uk 

Charles Breese, Hygea vct plc on 01280 703482 or larpentnewton@btinternet.com

Roland Cornish, Beaumont Cornish Limited on 020 7628 3396

 

website: www.hygeavct.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUSVSROUARUAA
Date   Source Headline
5th Apr 201912:47 pmRNSIssue of Equity
3rd Apr 201912:46 pmRNSIssue of Equity
29th Mar 20195:20 pmRNSRevised timetable
13th Mar 201912:03 pmRNSExtension of Offer
7th Mar 20193:22 pmRNSIssue of Equity
6th Mar 201910:30 amRNSInterim Dividend
6th Mar 20198:39 amRNSNet Asset Value(s)
28th Dec 20187:00 amRNSDividend Declaration
19th Dec 20182:21 pmRNSIssue of Equity
18th Dec 20189:56 amRNSUpdate on Hallmarq
17th Dec 20184:43 pmRNSReduction of Capital
29th Nov 20181:53 pmRNSHolding(s) in Company
23rd Nov 20187:00 amRNSUpdate for the quarter ended 30 September 2018
27th Sep 201810:59 amRNSIssue of Equity
23rd Apr 201812:43 pmRNSHolding(s) in Company
22nd May 201712:59 pmRNSHolding(s) in Company
24th Feb 201610:42 amRNSScancell to present at Biotech Capital
16th Feb 20159:47 amRNSHoldings in Company
24th Oct 20133:53 pmRNSInterim Management Statement
22nd Mar 20127:00 amRNSFinal Results
29th Oct 201011:18 amRNSInterim Management Statement
7th Sep 201011:34 amRNSDirector's Dealings
5th Aug 20107:00 amRNSHalf Yearly Report
7th May 20107:00 amRNSResults of AGM and IMS to 31 March 2010
31st Mar 20104:48 pmRNSAnnual Financial Report
22nd Jan 201012:26 pmRNSDeclaration of Interim Dividend
24th Sep 20099:43 amRNSDirector's Dealing
22nd Sep 200910:10 amRNSPortfolio Update
19th May 20099:42 amRNSIssue of Equity
15th May 20093:27 pmRNSIssue of Equity
12th May 20097:00 amRNSInterim Management Statement
6th May 20097:00 amRNSResults of AGM and Issue of Equity
30th Apr 20097:00 amRNSTotal Voting Rights
16th Apr 20097:00 amRNSAvailability of Annual Accounts and Offer Letter
9th Apr 20091:04 pmRNSIssue of Equity-Replacement
9th Apr 200912:41 pmRNSIssue of Equity
9th Apr 200912:39 pmRNSOffer to Shareholders
6th Apr 20094:32 pmRNSDirector's Dealings
2nd Apr 20097:00 amRNSAnnual Report & Accounts and Notice of AGM
19th Nov 20089:54 amRNSDirector's Dealings
14th Nov 20081:08 pmRNSInterim Management Statement
28th Aug 20087:00 amRNSInterim Results
1st Aug 20084:00 pmRNSIssue of Equity
22nd Jul 20083:11 pmRNSResult of AGM
30th May 20083:25 pmRNSIssue of Equity
15th May 20087:00 amRNSInterim Management Statement
1st May 200810:55 amRNSIssue of Equity
8th Apr 20085:18 pmRNSAnnual Information Update
3rd Apr 20083:42 pmRNSIssue of Equity
19th Mar 20085:02 pmRNSOffer to shareholders

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.